lunes, 18 de enero de 2016

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. - PubMed - NCBI

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. - PubMed - NCBI



 2016 Jan 9. [Epub ahead of print]

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety.

Abstract

BACKGROUND:

Predictive genetic testing has high impact on cancer prevention for BRCA carriers and passing this information in BRCA families is important. Mostly, this is proband-mediated but this path is defective and denies relatives lifesaving information.

OBJECTIVE:

To assess the efficacy/safety of an intervention, in which relatives are actively informed.

DESIGN:

Sequential prospective study in new BRCA families. The proband informed relatives about predictive testing (phase I). After 6 months, a letter was sent to adult relatives who had not been reached (phase II). Then a phone call was made to obtain a final notion of their wishes. All subjects received psychometric testing (State-Trait Anxiety Inventory, STAI), an interview and routine counselling.

RESULTS:

Twenty families were included. Twenty-four of the relatives could not be reached, 59 were 'decliners', 47 participated by the proband and 42 by the letter. Predictive testing was performed in 98 % of the participants of which 30 were mutation carriers. The intervention is psychologically safe: the 95 % CI for the estimated mean difference in STAI DY1 between phase II/I subjects (mean difference -1.07, 95 % CI -4.4 to 2.35, p = 0.53) shows that the mean STAI DY1 score (measured at first consult) for phase II is no more than 2.35 units higher than for phase I, which is not relevant.

CONCLUSIONS:

A protocol directly informing relatives nearly doubles the number of relatives tested and is psychologically safe. This should lead to a change in counselling guidelines in families with a strong germline predisposition for cancer.

KEYWORDS:

BRCA gene mutation; Efficacy; Predictive genetic counselling; Procedure; Safety

PMID:
 
26748927
 
[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario